59 -4 (90) 2026 - Amirjanova D.Z. - COMPARATIVE STUDY OF THE EFFECTIVENESS OF COGNITIVE-BEHAVIORAL PSYCHOTHERAPY IN THE TREATMENT OF CHRONIC INSOMNIA AT DIFFERENT PERIODS

COMPARATIVE STUDY OF THE EFFECTIVENESS OF COGNITIVE-BEHAVIORAL PSYCHOTHERAPY IN THE TREATMENT OF CHRONIC INSOMNIA AT DIFFERENT PERIODS

Amirjanova D.Z.- Tashkent State Medical University

Resume

Chronic insomnia is a disease characterized by difficulty falling asleep at night and sleep disturbances, with difficulties with nighttime sleep occurring 3 times a week and lasting up to 3 months. Insomnia is listed as a separate disease in the ICD-10 (2019) under the codes F51.0 (nonorganic insomnia), G47.00 (insomnia disorders). According to 2019 data, people with insomnia comprised 10% to 15% of the population, while in the first months of the pandemic this figure reached 17-33%. 150 patients diagnosed with chronic insomnia were recruited for the study. The dynamics of CBT-I in both groups were statistically analyzed. After using the CBT-I program, it was found that clinically and statistically significant positive changes (p <0.001) were observed in all primary parameters, chronic insomnia decreased by 25-52%. Based on the results of the study, an algorithm for the phased implementation of psychotherapy methods (CBT-I) in the post-pandemic period for the early diagnosis of chronic insomnia was developed.

Keywords: pandemic, CBT-I, chronic insomnia, anxiety, phobia, depression, insomnia severity index

First page

413

Last page

420

For citation:Amirjanova D.Z. - COMPARATIVE STUDY OF THE EFFECTIVENESS OF COGNITIVE-BEHAVIORAL PSYCHOTHERAPY IN THE TREATMENT OF CHRONIC INSOMNIA AT DIFFERENT PERIODS//New Day in Medicine 4(90)2026 413-420 https://newdayworldmedicine.com/en/new_day_medicine/4-90-2026

List of References

1. Ашуров ЗШ, Ражабов МН, Ядгарова НФ. Психологические и психические осложнения у больных с инфекцией COVID-19. Проблемы биологии и медицины. 2022;4(137):302–306.
2. Ибодуллаев ЗР, Карахонова СА, Сейткаримова ГС. Значение использования методов психокоррекции при лечении тревожно-фобического синдрома. Журнал неврологии и нейрохирургических исследований. 2021;1:38–41.
3. Маджидова ЁН, Ахмеджанова ЗБ. Когнитивные нарушения у больных, перенесших COVID-19 инфекцию. In: 5th International Conference on Research in Humanities, Applied Sciences and Education; 2022 Aug 30; Berlin, Germany. p. 67–69.
4. Магзумова ШШ, Ганиханов АА. Оценка заболеваемости психическими расстройствами в динамике в 2018–2021 гг. в Узбекистане. В: Самаркандская весенняя школа молодых психиатров и наркологов; 2022. p. 48.
5. Полуэктов МГ, Пчелина ПВ. Хроническая инсомния: современная модель «трех П» и основанные на ней методы лечения. Журнал неврологии и психиатрии им. С.С. Корсакова. 2015;115(12):141–147.
6. Полуэктов МГ. Сомнология и медицина сна. В: Национальное руководство памяти А.М. Вейна и Я.И. Левина. 2016. p. 298–310.
7. Рахимбаева ГС, Азимов А. Аспекты профилактики цереброваскулярных осложнений при COVID-19. Журнал неврологии и нейрохирургических исследований. 2021;2(4):30–36.
8. Хайдарова ДК, Сафаров К. Особенности психоэмоциональной сферы у больных, перенесших COVID-19, в зависимости от пола. Журнал неврологии и нейрохирургических исследований. 2021;2(4):39–45.
9. COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398:1700–1712. doi:10.1016/S0140-6736(21)02143-7.
10. Gallotti R, Valle F, Castaldo N, Sacco P, De Domenico M. Assessing the risks of ‘infodemics’ in response to COVID-19 epidemics. Nat Hum Behav. 2020;4(12):1285–1293. doi:10.1038/s41562-020-00994-6.

    file

    download